A Case of Chronic Conjunctivitis following Rituximab Therapy
Joint Authors
Quan, Walter D. Y.
Wang, Jun
Bautista, Marnelli A.
Source
Issue
Vol. 2009, Issue 2009 (31 Dec. 2009), pp.1-4, 4 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2009-09-01
Country of Publication
Egypt
No. of Pages
4
Main Subjects
Abstract EN
The activity of the anti-CD20 monoclonal antibody, rituximab in B-cell non-Hodgkin's lymphoma, with relatively minimal toxicity has been well established.
Adverse effects such as low-grade fever, urticaria, bronchospasm, sporadic tachycardia, and hypotension have been described.
However, only a single case of rituximab-related, transient conjunctivitis has been documented in literature.
We report an occurrence of chronic, bilateral conjunctivitis in an 88-year-old female diagnosed with stage IV, non-Hodgkin's lymphoma (NHL), who was maintained on rituximab for 12 months.
In contrast to the previously described case, our patient developed severe conjunctival inflammation approximately three to four weeks following rituximab induction.
Resolution of conjunctivitis occurred within two months after cessation of rituximab treatment.
American Psychological Association (APA)
Bautista, Marnelli A.& Quan, Walter D. Y.& Wang, Jun. 2009. A Case of Chronic Conjunctivitis following Rituximab Therapy. Advances in Hematology،Vol. 2009, no. 2009, pp.1-4.
https://search.emarefa.net/detail/BIM-459286
Modern Language Association (MLA)
Bautista, Marnelli A.…[et al.]. A Case of Chronic Conjunctivitis following Rituximab Therapy. Advances in Hematology No. 2009 (2009), pp.1-4.
https://search.emarefa.net/detail/BIM-459286
American Medical Association (AMA)
Bautista, Marnelli A.& Quan, Walter D. Y.& Wang, Jun. A Case of Chronic Conjunctivitis following Rituximab Therapy. Advances in Hematology. 2009. Vol. 2009, no. 2009, pp.1-4.
https://search.emarefa.net/detail/BIM-459286
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-459286